A phase I study of the combination of sorafenib (Sor) and bortezomib (Bor) in patients (pts) with metastatic melanoma (MM)

被引：0
|
作者：
Sullivan, Ryan J.
Ibrahim, Nageatte
Lawrence, Donald P.
Aldridge, Julie
Hodi, F. Stephen
Flaherty, Keith
Conley, Christine
DeNoble, Sarah
Mier, James Walter
Cho, Daniel C.
Atkins, Michael B.
McDermott, David F.
机构：
[1] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Dana Farber Canc Inst, Int Beast Canc Study Grp Stat Ctr, Boston, MA 02115 USA
[4] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA USA
[5] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[6] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9076
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase I Study of the Combination of Sorafenib and Temsirolimus in Patients with Metastatic Melanoma
    Davies, Michael A.
    Fox, Patricia S.
    Papadopoulos, Nicholas E.
    Bedikian, Agop Y.
    Hwu, Wen-Jen
    Lazar, Alexander J.
    Prieto, Victor G.
    Culotta, Kirk S.
    Madden, Timothy L.
    Xu, Quanyun
    Huang, Sha
    Deng, Wanleng
    Ng, Chaan S.
    Gupta, Sanjay
    Liu, Wenbin
    Dancey, Janet E.
    Wright, John J.
    Bassett, Roland L.
    Hwu, Patrick
    Kim, Kevin B.
    CLINICAL CANCER RESEARCH, 2012, 18 (04) : 1120 - 1128
  • [2] Phase I/II study of the combination of sorafenib and temsirolimus in patients with metastatic melanoma
    Kim, K. B.
    Davies, M. A.
    Papadopoulos, N. E.
    Bedikian, A. Y.
    Hwu, W.
    Woodard, K.
    Washington, E. W.
    Dancey, J. E.
    Wright, J.
    Hwu, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [3] Phase I/II study of the combination of decitabine (DAC) and temozolomide (TMZ) in patients (pts) with metastatic melanoma (MM)
    Tawbi, H. A.
    Beumer, J. H.
    Tarhini, A. A.
    Moschos, S. J.
    Egorin, M. J.
    Buch, S. C.
    Lin, Y.
    Kirkwood, J. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] A phase I study of high-dose calcitriol in combination with temozolomide for patients (Pts) with metastatic melanoma (MM)
    Pettijohn, Erin
    Rademaker, Alfred
    Martone, Brenda K.
    Poast, Erica
    Weitner, Bing Bing
    Eklund, John W.
    Kuzel, Timothy
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [5] A phase I dose escalation study with sorafenib (Sor) in combination with sirolimus (Sir) in patients (pts) with solid tumors
    van Herpen, C.
    Desar, I. M. E.
    Verijdt, R.
    van der Graaf, W. T. A.
    Timmer-Bonte, J. N. H.
    EJC SUPPLEMENTS, 2009, 7 (02): : 130 - 130
  • [6] Phase I study of nab-paclitaxel (NP) in combination with biochemotherapy (BCT) in patients (pts) with metastatic melanoma (MM)
    Alrwas, Anas
    Papadopoulos, Nicholas E.
    Cain, Suzanne
    Patel, Sapna Pradyuman
    Kim, Kevin B.
    Deburr, Tawania L.
    Bassett, Roland
    Hwu, Wen-Jen
    Bedikian, Agop Y.
    Davies, Michael A.
    Woodman, Scott Eric
    Hwu, Patrick
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] A phase I/II trial of the combination of bevacizumab, oxaliplatin, and sorafenib in patients with metastatic melanoma
    McClay, E. F.
    Bessudo, A.
    Frakes, L.
    Eisenberg, S.
    Just, R.
    Banerjee, P.
    Sinclair, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] A randomized phase II study of EMD 121974 in patients (pts) with metastatic melanoma (MM)
    Kim, K. B.
    Diwan, A. H.
    Papadopoulos, N. E.
    Bedikian, A. Y.
    Camacho, L. H.
    Hwu, P.
    Johnson, M. M.
    Colevas, A. D.
    Prieto, V. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] A phase II study of oral azacitidine (CC-486) in combination with pembrolizumab (PEMBRO) in patients (pts) with metastatic melanoma (MM).
    Burton, Elizabeth M.
    Woody, Timothy
    Glitza, Isabella Claudia
    Amaria, Rodabe Navroze
    Keung, Emily Zhi-Yun
    Diab, Adi
    Patel, Sapna Pradyuman
    Wong, Michael K. K.
    Yee, Cassian
    Hwu, Patrick
    McQuade, Jennifer Leigh
    Woodman, Scott Eric
    Tetzlaff, Michael T.
    Davies, Michael A.
    Wargo, Jennifer Ann
    Rai, Kunal
    Tawbi, Hussein Abdul-Hassan
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] Phase 1 study of sorafenib in combination with bortezomib in patients with advanced malignancies
    Shaji K. Kumar
    James Jett
    Randolph Marks
    Ronald Richardson
    Fernando Quevedo
    Timothy Moynihan
    Gary Croghan
    Svetomir N. Markovic
    Keith C. Bible
    Rui Qin
    Angelina Tan
    Julian Molina
    Scott H. Kaufmann
    Charles Erlichman
    Alex A. Adjei
    Investigational New Drugs, 2013, 31 : 1201 - 1206
12345